We investigated the feasibility, quality and safety of patient self-control
of oral anticoagulation. The patients were selected by their physicians on
the basis of criteria such as compliance, skills and motivation. After the
oretical and practical training they self-monitored and self-adjusted their
anticoagulant dosage for 6 months by weekly self-measurement of their INR
values using a capillary whole blood prothrombin time monitor (CoaguChek(R)
). Venous INR measurements once a month served as quality control. There we
re 51 study participants, who performed a median 5 INR measurements per mon
th. 75.8% of all registered INR values were within the recommended individu
al INR target ranges. The coefficient of correlation between capillary (y)
and venous (x) INR values was r = 0.87 (regression analysis y = 1.0 x -0.2)
. The concordance of capillary and venous INR values was 80% with respect t
o the individual INR target ranges. There were 5 minor bleeding episodes an
d no overt thromboembolic recurrences during the study period. In conclusio
n, the study demonstrated that patient self-control of oral anticoagulation
is feasible and achieves a high percentage of INR values within the recomm
ended target ranges. Therefore, self-control of oral anticoagulation can be
offered to skilled and motivated patients as an alternative to physician-g
uided anticoagulation. However, specific training of these selected patient
s is necessary.